High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis
Abstract There is no known biomarker that predicts the response to immune therapy in autoimmune synaptic encephalitis. Thus, we investigated serum albumin as a prognostic biomarker of early immune therapies in patients with autoimmune encephalitis. We enrolled patients who were diagnosed with defini...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2018-01-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-018-19490-z |